The risk is clearly on the downside. If the drug is rejected initially - the price falls to twenty cents. If the drug is accepted, the market then starts to focus on the low probability that biotechs face in actually making money from a drug.
I think the current price is a good risk / reward to SELL.
- Forums
- ASX - By Stock
- 2 weeks to go...
The risk is clearly on the downside. If the drug is rejected...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)